[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]

July 2019 - July 1883

Decade

Year

Issue

January 19, 2016, Vol 315, No. 3, Pages 223-318

In This Issue of JAMA

Highlights

Abstract Full Text
free access has audio
JAMA. 2016;315(3):223-225. doi:10.1001/jama.2015.14058
Original Investigation

Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries

Abstract Full Text
free access has multimedia has audio
JAMA. 2016;315(3):272-283. doi:10.1001/jama.2015.18603

This cohort study uses international claims and registry data to describe site of death, health care utilization, and hospital expenditures in the 180-day and 30-day periods before death among elderly patients with cancer in 7 developed countries.

Family Perspectives on Aggressive Cancer Care Near the End of Life

Abstract Full Text
free access
JAMA. 2016;315(3):284-292. doi:10.1001/jama.2015.18604

This study assesses associations between measures of aggressive end-of-life care and bereaved family members’ perceptions of the quality of care in Medicare beneficiaries who died of lung or colorectal cancer between 2003 and 2011.

Research Letter

Association of Occupation as a Physician With Likelihood of Dying in a Hospital

Abstract Full Text
free access
JAMA. 2016;315(3):301-303. doi:10.1001/jama.2015.16976

This prospective study uses US Census Bureau surveys matched to the National Death Index to compare the location of death for physicians with that of other health professionals, non–health care professionals with similar education levels, and the general population aged 30 to 98 years who died between 1979 and 2011.

End-of-Life Care Intensity for Physicians, Lawyers, and the General Population

Abstract Full Text
free access
JAMA. 2016;315(3):303-305. doi:10.1001/jama.2015.17408

This study uses Medicare death records to compare the intensity of end-of-life care received by physicians, lawyers, and the general US population.

Viewpoint

Responding to Patients Requesting Physician-Assisted Death: Physician Involvement at the Very End of Life

Abstract Full Text
JAMA. 2016;315(3):245-246. doi:10.1001/jama.2015.16210

This Viewpoint discusses why physician-assisted death should be considered important enough to be made legally available in all US states.

Why Physicians Should Oppose Assisted Suicide

Abstract Full Text
JAMA. 2016;315(3):247-248. doi:10.1001/jama.2015.16194

This Viewpoint reviews the historical roles and ethical obligations of physicians to relieve suffering and in those contexts argues that physician-assisted suicide is never justifiable.

Physician-Assisted Dying: A Turning Point?

Abstract Full Text
JAMA. 2016;315(3):249-250. doi:10.1001/jama.2015.16586

This Viewpoint discusses the debate over physician-assisted dying and the current turning point in public opinion regarding its support.

The Liberty to Die: California Enacts Physician Aid-in-Dying Law

Abstract Full Text
JAMA. 2016;315(3):251-252. doi:10.1001/jama.2015.16242

This Viewpoint traces the history of legalization of physician aid in dying, describes its operational constructs, discusses its ongoing challenges, and considers its future.

Physician-Assisted Death in Canada

Abstract Full Text
JAMA. 2016;315(3):253-254. doi:10.1001/jama.2015.17435

This Viewpoint describes efforts in Canada to explore the complexities of physician-assisted death after a 2015 Canadian Supreme Court ruling against its prohibition.

Toward Better ICU Use at the End of Life

Abstract Full Text
JAMA. 2016;315(3):255-256. doi:10.1001/jama.2015.18681

This Viewpoint examines arguments for and against intensive care for patients at the end of life and proposes strategies to ensure the delivery of appropriate and optimal patient-centered care.

A Policy Prescription for Hospice Care

Abstract Full Text
JAMA. 2016;315(3):257-258. doi:10.1001/jama.2015.18424

This Viewpoint proposes policy options to make hospice care more broadly available to patients and their physicians.

The Problems With Physician Orders for Life-Sustaining Treatment

Abstract Full Text
JAMA. 2016;315(3):259-260. doi:10.1001/jama.2015.17362

This Viewpoint argues that rapid expansion of programs that protect patients from unwanted resuscitation has outpaced the evidence supporting the programs and may compromise patient-centered decision making more broadly.

A Piece of My Mind

What Would Mom Want?

Abstract Full Text
JAMA. 2016;315(3):261-262. doi:10.1001/jama.2015.13326

A Final Course

Abstract Full Text
JAMA. 2016;315(3):263-264. doi:10.1001/jama.2015.17057

Hope Is the Thing With Feathers

Abstract Full Text
JAMA. 2016;315(3):265-266. doi:10.1001/jama.2015.18557
Editorial

Quantity and Quality of Life: Duties of Care in Life-Limiting Illness

Abstract Full Text
JAMA. 2016;315(3):267-269. doi:10.1001/jama.2015.19206

Death, Dying, and End of Life

Abstract Full Text
JAMA. 2016;315(3):270-271. doi:10.1001/jama.2015.19102
From the JAMA Network

Relationship of a Mandated 1-Hour Evacuation Policy and Outcomes for Combat Casualties

Abstract Full Text
JAMA. 2016;315(3):293-294. doi:10.1001/jama.2015.18744

This commentary discusses a study published in JAMA Surgery that investigated morbidity and mortality outcomes for battlefield casualties before and after implementation of a “golden hour” rule mandating prehospital helicopter transport of critically injured troops in 60 minutes or less.

JAMA Clinical Challenge

Alopecia in a Boy With Nephrotic Syndrome

Abstract Full Text
JAMA. 2016;315(3):295-296. doi:10.1001/jama.2015.13673

A 5-year-old boy presented with erythematous alopecia, crusting, and pustules on the right frontal scalp, without local warmth. He receives prednisone and cyclosporine for nephrotic syndrome; has cervical adenopathy; and owns a cat. Laboratory findings were unremarkable. What would you do next?

JAMA Diagnostic Test Interpretation

Electrodiagnostic Tests in Polyneuropathy and Radiculopathy

Abstract Full Text
has audio
JAMA. 2016;315(3):297-298. doi:10.1001/jama.2015.16832

A 66-year-old man with mild diabetes, coronary artery disease, and gout presented to the neuromuscular clinic with tingling and weakness in his legs. Results from a neurological examination found uncertainty of the localization of nerve injury, and electrodiagnostic testing revealed normal sural sensory responses. How do you interpret the test results?

Medical News & Perspectives

Greater Health Care Spending May Moderate Recession’s Negative Health Effects

Abstract Full Text
JAMA. 2016;315(3):237-239. doi:10.1001/jama.2015.16712

This Medical News & Perspectives article highlights a presentation at the American Public Health Association’s annual meeting that addressed economic conditions, health spending, and mortality.

News From the Food and Drug Administration

Cooling System to Prevent Hair Loss

Abstract Full Text
JAMA. 2016;315(3):243. doi:10.1001/jama.2015.18375

Update on SGLT2 Inhibitor Warning

Abstract Full Text
JAMA. 2016;315(3):243. doi:10.1001/jama.2015.18729

New Option for Bleeding Disorder

Abstract Full Text
JAMA. 2016;315(3):243. doi:10.1001/jama.2015.18731
The JAMA Forum

Communicating the Health Effects of Climate Change

Abstract Full Text
free access
JAMA. 2016;315(3):239-240. doi:10.1001/jama.2015.18271
Global Health

El Niño to Adversely Affect Children’s Health

Abstract Full Text
JAMA. 2016;315(3):242. doi:10.1001/jama.2015.17591

Lessons From Ebola Outbreak Point to Reforms

Abstract Full Text
JAMA. 2016;315(3):242. doi:10.1001/jama.2015.18458

Asymptomatic People May Contribute to Dengue Transmission

Abstract Full Text
JAMA. 2016;315(3):242. doi:10.1001/jama.2015.18460

WHO Survey Reveals Misconceptions About Antibiotic Resistance

Abstract Full Text
JAMA. 2016;315(3):242. doi:10.1001/jama.2015.18462
JAMA Infographic

Visualizing Health Metrics

When and Why People Die in the United States, 1990-2013

Abstract Full Text
free access
JAMA. 2016;315(3):241. doi:10.1001/jama.2015.17599
The Art of JAMA

The Doctor Henri Vaquez (1860-1936), Cardiologist: Édouard Vuillard

Abstract Full Text
JAMA. 2016;315(3):230-231. doi:10.1001/jama.2015.14060
Poetry and Medicine

Physicians

Abstract Full Text
JAMA. 2016;315(3):309. doi:10.1001/jama.2015.17343
JAMA Revisited

Euthanasia

Abstract Full Text
JAMA. 2016;315(3):310. doi:10.1001/jama.2015.17071
JAMA Patient Page

Death in the United States: Changes From 1969 to 2013

Abstract Full Text
free access
JAMA. 2016;315(3):318. doi:10.1001/jama.2015.17432
Comment & Response

Finerenone for Albuminuria in Patients With Diabetic Nephropathy

Abstract Full Text
JAMA. 2016;315(3):305-306. doi:10.1001/jama.2015.15996

Managing Chronic Kidney Disease in Older People

Abstract Full Text
JAMA. 2016;315(3):306-307. doi:10.1001/jama.2015.15993

Finerenone for Albuminuria in Patients With Diabetic Nephropathy—Reply

Abstract Full Text
JAMA. 2016;315(3):306. doi:10.1001/jama.2015.16014

Managing Chronic Kidney Disease in Older People—Reply

Abstract Full Text
JAMA. 2016;315(3):307-308. doi:10.1001/jama.2015.15999

Managing Chronic Kidney Disease in Older People—Reply

Abstract Full Text
JAMA. 2016;315(3):307. doi:10.1001/jama.2015.16002
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2016;315(3):227-228. doi:10.1001/jama.2015.14059
×